Quality & complianceOfficial
FDA lists Class II recall of Victory Medical Center Pharmacy tesamorelin 10mg/ml product
🇺🇸 FDA enforcement report · Wed 11 Nov 2026
The US regulator's enforcement report cites lack of processing controls for the compounded product, which was distributed in Colorado, Florida and Texas and remains under recall.
The US Food and Drug Administration has published a Class II recall in its enforcement report for tesamorelin (MDV) 10mg/ml, 3ml presentation, from Victory Medical Center Pharmacy. The entry is dated 11 November 2026 and carries recall number D-0143-2027.
Subscribe to keep reading
$4.99 / month
- Every article, analysis and opinion piece on VigiEye and CompePharma
- One subscription for both sites, cancel any time
or
Official source: FDA enforcement report ↗
Article written by VigiEye from the official source (FDA enforcement report). AI-assisted; check the source before acting.
More Quality & compliance
All →
BfArM publishes urgent field safety notice for Bentley InnoMed's BeFlow Iliac Covered Stent System
🇩🇪 BfArM field safety notices · Wed 18 Nov 2026
BfArM lists Siemens field safety notice for Dimension Urine Barbiturate Screen assay
🇩🇪 BfArM field safety notices · Wed 18 Nov 2026
BfArM publishes Medtronic MiniMed urgent field safety notice for MiniMed Go app
🇩🇪 BfArM field safety notices · Wed 18 Nov 2026
BfArM posts Merit Medical field safety notice for Philips BridgeT Balloon Prep Kit
🇩🇪 BfArM field safety notices · Wed 18 Nov 2026
BfArM posts Urgent Field Safety Notice for Biomet UK's Avantage Cup Gripper
🇩🇪 BfArM field safety notices · Wed 18 Nov 2026
BfArM publishes InterSystems field safety notice for TrakCare France software
🇩🇪 BfArM field safety notices · Wed 18 Nov 2026